Open AccessUNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
Author(s) -
Deborah DeRyckere,
Alisa B. Lee-Sherick,
Madeline G. Huey,
Amanda A. Hill,
Jeffrey W. Tyner,
Kristen M. Jacobsen,
Lauren S. Page,
Gregory D. Kirkpatrick,
Fatma Eryildiz,
Stephanie A. Montgomery,
Weihe Zhang,
Xiaodong Wang,
Stephen V. Frye,
H Shelton Earp,
Douglas K. Graham
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/wa7e-m156
Subject(s) - methotrexate , mertk , leukemia , small molecule , medicine , pharmacology , chemistry , cancer research , biochemistry , receptor , receptor tyrosine kinase